CSIMarket Company Name, Ticker, Customers, else..
 
Sophia Genetics Sa  (NASDAQ: SOPH)
Other Ticker:  
 
 
Price: $3.2900 $-0.10 -2.978%
Day's High: $3.45 Week Perf: 1.23 %
Day's Low: $ 3.20 30 Day Perf: -9.62 %
Volume (M): 32 52 Wk High: $ 7.37
Volume (M$): $ 105 52 Wk Avg: $4.37
Open: $3.39 52 Wk Low: $2.70



 Market Capitalization (Millions $) 213
 Shares Outstanding (Millions) 65
 Employees -
 Revenues (TTM) (Millions $) 62
 Net Income (TTM) (Millions $) -79
 Cash Flow (TTM) (Millions $) 161
 Capital Exp. (TTM) (Millions $) 1

Sophia Genetics Sa
Sophia Genetics SA is a global health technology company that specializes in artificial intelligence and data-driven solutions for providing insights into the treatment and prevention of cancer and genetic diseases. The company's platform incorporates advanced technology, including machine learning and cloud computing, to analyze genomic and clinical data, enabling healthcare professionals to make more informed decisions and personalize patient care. Sophia Genetics collaborates with hospitals and laboratories worldwide to develop and implement genomic testing and data analysis solutions, contributing to advancements in precision medicine.


   Company Address: La Pi?ce 12 Rolle 0
   Company Phone Number: 982-1210   Stock Exchange / Ticker: NASDAQ SOPH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EXAS      % 
FLGT      % 
GH        1.65% 
ILMN        1.65% 
NTRA        1.65% 
• View Complete Report
   



Products & Services

SOPHiA GENETICS Unveils Groundbreaking Whole Genome Sequencing Solution Powered by Micr...

Published Wed, May 29 2024 2:00 PM UTC

SOPHiA GENETICS, a prominent cloud-native healthcare technology company and a trailblazer in the global biotechnology industry, has announced a groundbreaking collaboration with tech giants Microsoft and NVIDIA. The partnership aims to develop an advanced whole genome analytical solution that will revolutionize the field of genetic sequencing.With advancements in genomic an...
Sophia Genetics Sa

Analysis of Sophia Genetics Sa's Fourth Quarter Financial Performance2.



Sophia Genetics Sa, a biotechnology and pharmaceutical company, has recently reported financial results for the fourth quarter of 2023, which have raised concerns about the company's prospects. While its revenue showed significant growth compared to the previous year, the company still reported a substantial loss per share. This article aims to provide an in-depth analysis of Sophia Genetics, highlighting its financial challenges and industry dynamics that could further hinder its growth potential.
Financial Performance and Revenue Surge
In the financial fourth quarter of 2023, Sophia Genetics Sa revealed a loss of $-1.22 per share, indicating a deterioration from the previous year's loss of $-1.36 per share. Despite this concerning decline, the company's revenue surged by an impressive 30.179% to $61.91 million from the comparable reporting period a year earlier. This impressive growth in revenue outperformed many of its industry peers who witnessed significant revenue declines during the same period.






Sophia Genetics Sa's Segments

  Sophia Genetics Sa Outlook

On May 7 2024 the Sophia Genetics Sa provided following guidance

Sophia Genetics Sa. has released its first quarter 2024 results, showcasing consistent operational execution and strong new business momentum. Despite challenges in the market, the company has managed to maintain a steady performance and reaffirms its guidance for the coming quarters.

The company's ability to continue its operational execution amidst market volatility is a testament to its resilience and strategic planning. By capitalizing on new business opportunities, Sophia Genetics Sa. has managed to sustain its growth trajectory and position itself for future success.

The reaffirmation of guidance further solidifies the company's confidence in its strategies and ability to navigate any cha...





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com